The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note
Frank, L.
Pediatrics 88(2): 413-416
1991
ISSN/ISBN: 0031-4005 PMID: 1741827 Document Number: 383277
Document emailed within 1 workday
Related Documents
Perlman, J.M.; Volpe, J.J. 1989: Movement disorder of premature infants with severe bronchopulmonary dysplasia: a new syndrome Pediatrics 84(2): 215-218Okura, M.; Sato, Y.; Takeuchi, Y.; Ono, T.; Hashimoto, T.; Nishigaki, K. 1998: Multicenter study on clinical effects of a small dose of erythromycin on chronic lung disorders of premature infants--single blind comparison of treated and untreated groups. A committee for the Study of EM Therapy for Chronic Lung Diseases of Premature Infants Japanese Journal of Antibiotics 51 Suppl A: 103-106
Sobel, D.B.; Philip, A.G. 1992: Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia Pediatrics 90(4): 529-533
Kiatchoosakun, P.; Jirapradittha, J.; Panthongviriyakul, M.Charnchai.; Khampitak, T.; Yongvanit, P.; Boonsiri, P. 2014: Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial Journal of the Medical Association of Thailand 97 Suppl. 10: S82-S88
Abdul-Wahab, A.; Bessisso, M.S.; Elsaid, M.F. 2002: Sandhoff disease (GM2 Gangliosidoses) in a premature patient with bronchopulmonary dysplasia Saudi Medical Journal 23(5): 602-605
Vik, T.; Hanch-Hansen, V.; Brubakk, A.M. 1989: Late mortality among small premature infants. Significance of respiratory distress and bronchopulmonary dysplasia for early and late mortality among infants with birth weights lower than 1,501 g Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(10): 1059-1062
Heimler, R.; Hoffmann, R.G.; Starshak, R.J.; Sasidharan, P.; Grausz, J.P. 1988: Chronic lung disease in premature infants: a retrospective evaluation of underlying factors Critical Care Medicine 16(12): 1213-1217
Frank, L.; Lecuona, P.C. 1996: Dexamethasone and bronchopulmonary dysplasia Pediatrics 98(3 Part 1): 514-515
Patrick, C.H.; Lazarchick, J.; Horn, B.S. 1993: Alterations in von Willebrand factor antigen in premature infants with respiratory distress syndrome and chronic lung disease Annals of Clinical and Laboratory Science 23(1): 39-46
Raupp, P. 2001: Folate and vitamin B12 supplementation in very low birth weight infants treated with erythropoietin: a cautionary note Pediatrics 108(1): 217
Kao, L.C.; Warburton, D.; Cheng, M.H.; Cedeño, C.; Platzker, A.C.; Keens, T.G. 1984: Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial Pediatrics 74(1): 37-44
Aliamovskaia, G.A.; Keshinian, E.S. 2012: Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 30; 32-34
Nickerson, B.G.; Taussig, L.M. 1980: Family history of asthma in infants with bronchopulmonary dysplasia Pediatrics 65(6): 1140-1144
Parmigiani, S.; Ubaldi, A.; Capuano, C.; Massinissa Magini, G.; Bianchi, M.E. 2001: Palivizumab in infants with gestational age < or = 28 weeks and bronchopulmonary dysplasia Acta Bio-Medica de l'Ateneo Parmense 72(5-6): 109-113
Solimano, A.J.; Smyth, J.A.; Mann, T.K.; Albersheim, S.G.; Lockitch, G. 1986: Pulse oximetry advantages in infants with bronchopulmonary dysplasia Pediatrics 78(5): 844-849
Berman, W.; Yabek, S.M.; Dillon, T.; Burstein, R.; Corlew, S. 1982: Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization Pediatrics 70(5): 708-712
Hefti, U.; Kulstrunk, M. 1991: A case from practice (220). Allergic bronchopulmonary aspergillosis. Aspergilloma in the left upper lobe following chronic abscessed pneumonia. Chronic obstructive lung disease Schweizerische Rundschau für Medizin Praxis 80(27-28): 753-755
Rome, E.S.; Stork, E.K.; Carlo, W.A.; Martin, R.J. 1984: Limitations of transcutaneous PO2 and PCO2 monitoring in infants with bronchopulmonary dysplasia Pediatrics 74(2): 217-220
Moyer-Mileur, L.J.; Nielson, D.W.; Pfeffer, K.D.; Witte, M.K.; Chapman, D.L. 1996: Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia Pediatrics 98(4 Pt 1): 779-783
Fox, W.W. 1978: Bronchopulmonary dysplasia [respirator lung syndrome]: clinical course and outpatient therapy Pediatric Annals 7(1): 75; 78-79; 82-83 Passim